ANI Pharmaceuticals, Inc. (ANIP)
| Previous close | 55.48 |
| Open | 53.51 |
| Bid | 54.98 x 100 |
| Ask | 55.07 x 100 |
| Day's range | 52.57 - 55.34 |
| 52-week range | 48.20 - 70.81 |
| Volume | |
| Avg. volume | 297,762 |
| Market cap | 1.164B |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 46.50 |
| EPS (TTM) | 1.19 |
| Earnings date | 06 Nov 2024 - 11 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 83.40 |
- Business Wire
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
PRINCETON, N.J. & ATLANTA, September 11, 2024--ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) ("ANI") and Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera" or the "Company") today jointly announced that they have scheduled the closing of their transaction pursuant to the companies’ previously announced Merger Agreement for before the market opens on Monday, September 16, 2024.
GlobeNewswireANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. (“Alimera”) (Nasdaq: ALIM). We note the Alimera press release issued today. The Company continues to work in good faith toward closing of the acquisition. Any delay is a result of discussions regarding closing conditions, which the Company expects to resolve
Insider MonkeyANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) stands against the other cheap pharmaceutical stocks. The pharmaceutical industry is one of the most interesting sectors to invest in. This is because […]
